Fibroadenoma Market Overview

Fibroadenomas are benign tumours of the breast which are characterized by a mixture of stromal and epithelial tissue. Fibroadenomas develop from the milk producing glands to form a solid lump. Fibroadenomas are caused due to hormone imbalances and the symptoms are painless, firm, mobile lump in the breast of a woman. According to American Cancer Society, fibroadenomas are most common in young women in their 20s and 30s, although they can be found in women of any age. The growth of these tumours is faster during pregnancy while menopause, causes them to shrink.The market for treatment of fibroadenomas is growing due to factors such as growing use of hormonal contraceptives which increases the chances of fibroadenomas, genetic predisposition, greater screening rates, growing awareness etc. Obesity also increases the chances of developing fibroadenoma Breast. The market restraints are the non-life threatening nature of the fibroadenomas, the self-resolving nature of Fibroadenomas etc.

The Fibroadenoma Market is projected to reach USD 1,093.6 Million by 2030 at 6.5% CAGR during the forecast period 2022-2030.

The market for treatment of fibroadenomas is growing due to factors such as growing use of hormonal contraceptives which increases the chances of fibroadenomas, genetic predisposition, greater screening rates, growing awareness etc. Obesity also increases the chances of developing fibroadenoma Breast. The Fibroadenoma Market restraints are the non-life threatening nature of the fibroadenomas, the self-resolving nature of Fibroadenomas etc.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/3997

Key players profiled in the report are ICECURE MEDICAL, Alpinion Medical Systems Co., Ltd., SonaCare Medical, LLC, Insightec, Torrent Pharmaceuticals Ltd, Taj Pharmaceuticals Ltd., Novartis Pharmaceuticals Limited, Torrent Pharmaceuticals Limited, and others.

Taste the market data and market information presented through more than 50 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content (TOC) market synopsis on “Global Fibroadenoma market” Research Report – Forecast to 2023.

Fibroadenoma Market Segmentation

The global fibroadenoma market is segmented on the basis of types, diagnosis, treatment, and end users. Based on types, the market has been segmented as simple fibroadenoma and complex fibroadenoma. Based on the diagnosis, the market has been segmented as physical examination, ultrasound scan, mammogram, biopsy and others. Based on the treatment, the market has been segmented as cryoablation, High Intensity Focused Ultrasound (HIFU), drugs, surgery and others. Based on the end users, the market has been segmented as hospitals and clinics, diagnostic centers and others.

Fibroadenoma Market Regional Analysis

Europe holds the second position in the market due to rising awareness and high disposable incomes of patients. Innovations in this region are also expected to drive market growth during the forecast period. For instance, Theraclion, a French firm, devised EchoPulse focused ultrasound system for treating fibroadenomas and won the European CE Mark approval. This device uses ultrasound to detect and attack tumors in real time without the need for general anesthesia. Asia Pacific is expected to grow at a rapid growth rate in the coming years. It is likely to be led by China and India.

Regions covered in the fibroadenoma market are North America, Europe, Asia Pacific, and Middle East and Africa (MEA). In the North America market, the United States is considered to hold the maximum market share owing to attractive insurance schemes and higher budgetary expenditure for the healthcare sector. Adoption of new devices and technologies in the U.S. is also an important factor catapulting the North America market to the topmost position.

The MEA market is expected to witness a moderate growth owing to poor political and economic conditions and poor healthcare penetration.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/fibroadenoma-market-3997

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: [email protected]